A NOVEL CLASS OF ANTAGONISTS FOR ROBUST INHIBITION OF MUTANT ESTROGEN RECEPTOR ACTION IN EDOCRINE RESISTANT METASTATIC BREAST CANCER
$470,775FY2019Defense Health AgencyDOD
The Trustees Of The Stevens Institute Of Technology, Hoboken NJ
The Trustees Of The Stevens Institute Of Technology, Hoboken NJ